Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups.

Dodd LE, Follmann D, Proschan M, Wang J, Malvy D, van Griensven J, Ciglenecki I, Horby PW, Ansumana R, Jiang JF, Davey RT, Lane HC, Gouel-Cheron A.

Sci Transl Med. 2019 Nov 27;11(520). pii: eaaw1049. doi: 10.1126/scitranslmed.aaw1049.

PMID:
31776287
2.

Longitudinal evaluation of asymptomatic Leishmania infection in HIV-infected individuals in North-West Ethiopia: A pilot study.

van Griensven J, van Henten S, Mengesha B, Kassa M, Adem E, Endris Seid M, Abdellati S, Asefa W, Simegn T, Debasu D, Bogale T, Gedamu Y, Van Den Bossche D, Adriaensen W, Van der Auwera G, Cnops L, Vogt F, Diro E.

PLoS Negl Trop Dis. 2019 Oct 8;13(10):e0007765. doi: 10.1371/journal.pntd.0007765. eCollection 2019 Oct.

3.

Time of administration of rabies immunoglobulins and adequacy of antibody response upon post-exposure prophylaxis: a descriptive retrospective study in Belgium.

Soentjens P, Croughs M, Burm C, Declerq S, Clerinx J, Maniewski U, Van Den Broucke S, Theunissen C, Huits R, Brosius I, Florence E, Kenyon C, Van Griensven J, Van Ierssel S, Lynen L, Balliauw K, Van Gucht S, Van Esbroeck M, Vlieghe E, Bottieau E, Van Herrewege Y.

Acta Clin Belg. 2019 Sep 4:1-7. doi: 10.1080/17843286.2019.1662993. [Epub ahead of print]

PMID:
31483218
4.

Cutaneous Leishmaniasis Due to Leishmania aethiopica.

van Henten S, Adriaensen W, Fikre H, Akuffo H, Diro E, Hailu A, Van der Auwera G, van Griensven J.

EClinicalMedicine. 2019 Jan 8;6:69-81. doi: 10.1016/j.eclinm.2018.12.009. eCollection 2018 Dec. Review.

5.

Neglected tropical diseases and the sustainable development goals: an urgent call for action from the front line.

Addisu A, Adriaensen W, Balew A, Asfaw M, Diro E, Garba Djirmay A, Gebree D, Seid G, Begashaw H, Harries AD, Hirpa Adugna A, Ayalew Jejaw Z, Kamau EM, Kelbo T, Manzi M, Medebo Daniel D, Moloo A, Olliaro P, Owiti P, Reeder JC, Senkoro M, Takarinda K, Terry R, Timire C, Tucho S, Tweya H, Wendemagegn Y, Verdonck K, Vogt F, van Henten S, van Griensven J, Worku B, Zolfo M, Zachariah R; Ethiopia SORT IT Neglected Tropical Diseases Group.

BMJ Glob Health. 2019 Feb 8;4(1):e001334. doi: 10.1136/bmjgh-2018-001334. eCollection 2019. No abstract available. Erratum in: BMJ Glob Health. 2019 Mar 19;4(2):e001334corr1.

6.

Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia.

Diro E, Edwards T, Ritmeijer K, Fikre H, Abongomera C, Kibret A, Bardonneau C, Soipei P, Mutinda B, Omollo R, van Griensven J, Zijlstra EE, Wasunna M, Alves F, Alvar J, Hailu A, Alexander N, Blesson S.

PLoS Negl Trop Dis. 2019 Feb 21;13(2):e0007132. doi: 10.1371/journal.pntd.0007132. eCollection 2019 Feb.

7.

Ebola virus disease.

Malvy D, McElroy AK, de Clerck H, Günther S, van Griensven J.

Lancet. 2019 Mar 2;393(10174):936-948. doi: 10.1016/S0140-6736(18)33132-5. Epub 2019 Feb 15. Review. Erratum in: Lancet. 2019 May 18;393(10185):2038.

PMID:
30777297
8.

Visceral Leishmaniasis: Recent Advances in Diagnostics and Treatment Regimens.

van Griensven J, Diro E.

Infect Dis Clin North Am. 2019 Mar;33(1):79-99. doi: 10.1016/j.idc.2018.10.005. Review.

9.

Where are the Ebola diagnostics from last time?

Cnops L, De Smet B, Mbala-Kingebeni P, van Griensven J, Ahuka-Mundeke S, Ariën KK.

Nature. 2019 Jan;565(7740):419-421. doi: 10.1038/d41586-019-00212-y. No abstract available.

PMID:
30670861
10.

Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients.

Adriaensen W, Abdellati S, van Henten S, Gedamu Y, Diro E, Vogt F, Mengesha B, Adem E, Kestens L, van Griensven J.

Front Cell Infect Microbiol. 2018 Dec 11;8:428. doi: 10.3389/fcimb.2018.00428. eCollection 2018.

11.

What motivates Ebola survivors to donate plasma during an emergency clinical trial? The case of Ebola-Tx in Guinea.

Ronse M, Marí Sáez A, Gryseels C, Bannister-Tyrrell M, Delamou A, Guillard A, Briki M, Bigey F, Haba N, van Griensven J, Peeters Grietens K.

PLoS Negl Trop Dis. 2018 Oct 17;12(10):e0006885. doi: 10.1371/journal.pntd.0006885. eCollection 2018 Oct.

12.

Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia.

Vogt F, Mengesha B, Asmamaw H, Mekonnen T, Fikre H, Takele Y, Adem E, Mohammed R, Ritmeijer K, Adriaensen W, Melsew Y, van Griensven J, Diro E.

Am J Trop Med Hyg. 2018 Oct;99(4):957-966. doi: 10.4269/ajtmh.18-0042.

13.

The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.

Abongomera C, Diro E, de Lima Pereira A, Buyze J, Stille K, Ahmed F, van Griensven J, Ritmeijer K.

PLoS Negl Trop Dis. 2018 May 25;12(5):e0006527. doi: 10.1371/journal.pntd.0006527. eCollection 2018 May.

14.

Symptom-Based Ebola Risk Score for Ebola Virus Disease, Conakry, Guinea.

Ingelbeen B, De Weggheleire A, Van Herp M, van Griensven J.

Emerg Infect Dis. 2018 Jun;24(6):1162. doi: 10.3201/eid2406.171812. No abstract available.

15.

New insights into leishmaniasis in the immunosuppressed.

Akuffo H, Costa C, van Griensven J, Burza S, Moreno J, Herrero M.

PLoS Negl Trop Dis. 2018 May 10;12(5):e0006375. doi: 10.1371/journal.pntd.0006375. eCollection 2018 May. Review.

16.

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?

van Griensven J, Mohammed R, Ritmeijer K, Burza S, Diro E.

Open Forum Infect Dis. 2018 Mar 16;5(4):ofy059. doi: 10.1093/ofid/ofy059. eCollection 2018 Apr.

17.

Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia.

van Griensven J, Mengesha B, Mekonnen T, Fikre H, Takele Y, Adem E, Mohammed R, Ritmeijer K, Vogt F, Adriaensen W, Diro E.

Front Cell Infect Microbiol. 2018 Mar 29;8:94. doi: 10.3389/fcimb.2018.00094. eCollection 2018.

18.

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone.

Tedder RS, Samuel D, Dicks S, Scott JT, Ijaz S, Smith CC, Adaken C, Cole C, Baker S, Edwards T, Kamara P, Kargbo O, Niazi S, Nwakanma D, d'Alessandro U, Burch G, Doughty H, Brown CS, Andrews N, Glynn JR, van Griensven J; Ebola_CP Consortium Investigators, Pollakis G, Paxton WA, Semple MG.

Transfusion. 2018 May;58(5):1289-1298. doi: 10.1111/trf.14580. Epub 2018 Mar 23.

19.

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.

Adriaensen W, Dorlo TPC, Vanham G, Kestens L, Kaye PM, van Griensven J.

Front Immunol. 2018 Jan 12;8:1943. doi: 10.3389/fimmu.2017.01943. eCollection 2017. Review.

20.

Visceral Leishmaniasis and HIV Co-Infection in Northwest Ethiopia: Antiretroviral Treatment and Burden of Disease among Patients Enrolled in HIV Care.

van Griensven J, Simegn T, Endris M, Diro E.

Am J Trop Med Hyg. 2018 Feb;98(2):486-491. doi: 10.4269/ajtmh.17-0142. Epub 2017 Nov 30.

21.

The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study.

Abongomera C, Diro E, Vogt F, Tsoumanis A, Mekonnen Z, Admassu H, Colebunders R, Mohammed R, Ritmeijer K, van Griensven J.

Clin Infect Dis. 2017 Oct 30;65(10):1703-1710. doi: 10.1093/cid/cix607.

22.

Engagement of public and private medical facilities in tuberculosis care in Myanmar: contributions and trends over an eight-year period.

Nwe TT, Saw S, Le Win L, Mon MM, van Griensven J, Zhou S, Chinnakali P, Shah S, Thein S, Aung ST.

Infect Dis Poverty. 2017 Sep 1;6(1):123. doi: 10.1186/s40249-017-0337-8.

23.

A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.

De Weggheleire A, An S, De Baetselier I, Soeung P, Keath H, So V, Ros S, Teav S, Smekens B, Buyze J, Florence E, van Griensven J, Thai S, Francque S, Lynen L.

PLoS One. 2017 Aug 23;12(8):e0183530. doi: 10.1371/journal.pone.0183530. eCollection 2017.

24.

Using mobile phones to ensure that referred tuberculosis patients reach their treatment facilities: a call that makes a difference.

Choun K, Achanta S, Naik B, Tripathy JP, Thai S, Lorent N, Khun KE, van Griensven J, Kumar AMV, Zachariah R.

BMC Health Serv Res. 2017 Aug 22;17(1):575. doi: 10.1186/s12913-017-2511-x.

25.

Ebola and community health worker services in Kenema District, Sierra Leone: please mind the gap!

Vandi MA, van Griensven J, Chan AK, Kargbo B, Kandeh JN, Alpha KS, Sheriff AA, Momoh KSB, Gamanga A, Najjemba R, Mishra S.

Public Health Action. 2017 Jun 21;7(Suppl 1):S55-S61. doi: 10.5588/pha.16.0082.

26.

Life goes on: the resilience of maternal primary care during the Ebola outbreak in rural Sierra Leone.

Caulker VML, Mishra S, van Griensven J, Moosa A, Najjemba R, Shringarpure K, Chan AK.

Public Health Action. 2017 Jun 21;7(Suppl 1):S40-S46. doi: 10.5588/pha.16.0083.

27.

Increase in acute malnutrition in children following the 2014-2015 Ebola outbreak in rural Sierra Leone.

Kamara MH, Najjemba R, van Griensven J, Yorpoi D, Jimissa AS, Chan AK, Mishra S.

Public Health Action. 2017 Jun 21;7(Suppl 1):S27-S33. doi: 10.5588/pha.16.0084.

28.

Clinical features and treatment response of cutaneous leishmaniasis in North-West Ethiopia.

Fikre H, Mohammed R, Atinafu S, van Griensven J, Diro E.

Trop Med Int Health. 2017 Oct;22(10):1293-1301. doi: 10.1111/tmi.12928. Epub 2017 Aug 13.

29.

Influence of the 2014-2015 Ebola outbreak on the vaccination of children in a rural district of Guinea.

Camara BS, Delamou AM, Diro E, El Ayadi A, Béavogui AH, Sidibé S, Grovogui FM, Takarinda KC, Kolié D, Sandouno SD, Okumura J, Baldé MD, Van Griensven J, Zachariah R.

Public Health Action. 2017 Jun 21;7(2):161-167. doi: 10.5588/pha.16.0120.

30.

Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso.

Guiraud I, Post A, Diallo SN, Lompo P, Maltha J, Thriemer K, Tahita CM, Ley B, Derra K, Bottieau E, Kazienga A, Schurmans C, Ravinetto R, Rouamba E, Van Griensven J, Bertrand S, Tinto H, Jacobs J.

PLoS One. 2017 Jul 10;12(7):e0178577. doi: 10.1371/journal.pone.0178577. eCollection 2017.

31.

Mortality among PCR negative admitted Ebola suspects during the 2014/15 outbreak in Conakry, Guinea: A retrospective cohort study.

Ingelbeen B, Bah EI, Decroo T, Balde I, Nordenstedt H, van Griensven J, De Weggheleire A.

PLoS One. 2017 Jun 30;12(6):e0180070. doi: 10.1371/journal.pone.0180070. eCollection 2017.

32.

The predicament of patients with suspected Ebola.

Colebunders R, Jacob ST, van Griensven J.

Lancet Glob Health. 2017 Jul;5(7):e658. doi: 10.1016/S2214-109X(17)30214-0. No abstract available.

33.

Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.

Abongomera C, Ritmeijer K, Vogt F, Buyze J, Mekonnen Z, Admassu H, Colebunders R, Mohammed R, Lynen L, Diro E, van Griensven J.

PLoS One. 2017 Jun 5;12(6):e0178996. doi: 10.1371/journal.pone.0178996. eCollection 2017.

34.

Malaria profiles and challenges in artemisinin resistance containment in Myanmar.

Nwe TW, Oo T, Wai KT, Zhou S, van Griensven J, Chinnakali P, Shah S, Thi A.

Infect Dis Poverty. 2017 Apr 25;6(1):76. doi: 10.1186/s40249-017-0292-4.

35.

Convalescent Plasma and the Dose of Ebola Virus Antibodies.

van Griensven J, Gallian P, de Lamballerie X.

N Engl J Med. 2017 Mar 30;376(13):1297. doi: 10.1056/NEJMc1700090. No abstract available.

PMID:
28355507
36.

Effect of the 2014/2015 Ebola outbreak on reproductive health services in a rural district of Guinea: an ecological study.

Camara BS, Delamou A, Diro E, Béavogui AH, El Ayadi AM, Sidibé S, Grovogui FM, Takarinda KC, Bouedouno P, Sandouno SD, Okumura J, Baldé MD, Van Griensven J, Zachariah R.

Trans R Soc Trop Med Hyg. 2017 Jan 1;111(1):22-29. doi: 10.1093/trstmh/trx009.

37.

Safety of a topical insect repellent (picaridin) during community mass use for malaria control in rural Cambodia.

Heng S, Sluydts V, Durnez L, Mean V, Polo K, Tho S, Coosemans M, van Griensven J.

PLoS One. 2017 Mar 24;12(3):e0172566. doi: 10.1371/journal.pone.0172566. eCollection 2017.

38.

International non-governmental organizations' provision of community-based tuberculosis care for hard-to-reach populations in Myanmar, 2013-2014.

Soe KT, Saw S, van Griensven J, Zhou S, Win L, Chinnakali P, Shah S, Mon MM, Aung ST.

Infect Dis Poverty. 2017 Mar 24;6(1):69. doi: 10.1186/s40249-017-0285-3.

39.

Relationship Between Time to Initiation of Antiretroviral Therapy and Treatment Outcomes: A Cohort Analysis of ART Eligible Adolescents in Zimbabwe.

Vogt F, Rehman AM, Kranzer K, Nyathi M, Van Griensven J, Dixon M, Ndebele W, Gunguwo H, Colebunders R, Ndlovu M, Apollo T, Ferrand RA.

J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):390-398. doi: 10.1097/QAI.0000000000001274.

40.

Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies.

van Griensven J, Edwards T, Baize S; Ebola-Tx Consortium.

N Engl J Med. 2016 Dec 8;375(23):2307-2309. doi: 10.1056/NEJMc1609116. Epub 2016 Nov 14. No abstract available.

41.

Profile and reintegration experience of Ebola survivors in Guinea: a cross-sectional study.

Delamou A, Camara BS, Kolie JP, Guemou AD, Haba NY, Marquez S, Beavogui AH, Delvaux T, van Griensven J.

Trop Med Int Health. 2017 Mar;22(3):254-260. doi: 10.1111/tmi.12825. Epub 2017 Jan 13.

42.

Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015.

van Griensven J, Bah EI, Haba N, Delamou A, Camara BS, Olivier KJ, De Clerck H, Nordenstedt H, Semple MG, Van Herp M, Buyze J, De Crop M, Van Den Broucke S, Lynen L, De Weggheleire A; Ebola-Tx Consortium.

Emerg Infect Dis. 2016 Dec;22(12). doi: 10.3201/eid2212.161136.

43.

Diagnosis of Visceral Leishmaniasis Using Peripheral Blood Microscopy in Ethiopia: A Prospective Phase-III Study of the Diagnostic Performance of Different Concentration Techniques Compared to Tissue Aspiration.

Diro E, Yansouni CP, Takele Y, Mengesha B, Lynen L, Hailu A, van Griensven J, Boelaert M, Büscher P.

Am J Trop Med Hyg. 2017 Jan 11;96(1):190-196. doi: 10.4269/ajtmh.16-0362. Epub 2016 Oct 31.

44.

Brief Report: Decentralizing ART Supply for Stable HIV Patients to Community-Based Distribution Centers: Program Outcomes From an Urban Context in Kinshasa, DRC.

Vogt F, Kalenga L, Lukela J, Salumu F, Diallo I, Nico E, Lampart E, Van den Bergh R, Shah S, Ogundahunsi O, Zachariah R, Van Griensven J.

J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):326-331. doi: 10.1097/QAI.0000000000001215.

45.

Overlooking the importance of immunoassays - Authors' reply.

Cnops L, van Griensven J, Honko AN, Bausch DG, Sprecher A, Hill CE, Colebunders R, Johnson JC, Griffiths A, Palacios GF, Kraft CS, Kobinger G, Hewlett A, Norwood DA, Sabeti P, Jahrling PB, Formenty P, Kuhn JH, Ariën KK.

Lancet Infect Dis. 2016 Oct;16(10):1110. doi: 10.1016/S1473-3099(16)30339-5. Epub 2016 Sep 19. No abstract available.

PMID:
27676345
46.

Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea.

Delamou A, Haba NY, Mari-Saez A, Gallian P, Ronse M, Jacobs J, Camara BS, Kadio KJO, Guemou A, Kolie JP, Crop M, Chavarin P, Jacquot C, Lazaygues C, Weggheleire A, Lynen L, van Griensven J.

Am J Trop Med Hyg. 2016 Sep 7;95(3):647-653. doi: 10.4269/ajtmh.15-0890. Epub 2016 Jul 18.

47.

High mortality in tuberculosis patients despite HIV interventions in Swaziland.

Mchunu G, van Griensven J, Hinderaker SG, Kizito W, Sikhondze W, Manzi M, Dlamini T, Harries AD.

Public Health Action. 2016 Jun 21;6(2):105-10. doi: 10.5588/pha.15.0081.

48.

Convalescent Plasma for Ebola Virus Disease.

van Griensven J, Edwards T, Gallian P; Ebola-Tx Consortium.

N Engl J Med. 2016 Jun 23;374(25):2500. doi: 10.1056/NEJMc1602284. No abstract available.

PMID:
27332913
49.

Essentials of filoviral load quantification.

Cnops L, van Griensven J, Honko AN, Bausch DG, Sprecher A, Hill CE, Colebunders R, Johnson JC, Griffiths A, Palacios GF, Kraft CS, Kobinger G, Hewlett A, Norwood DA, Sabeti P, Jahrling PB, Formenty P, Kuhn JH, Ariën KK.

Lancet Infect Dis. 2016 Jul;16(7):e134-e138. doi: 10.1016/S1473-3099(16)30063-9. Epub 2016 Jun 10. Review.

PMID:
27296694
50.

Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review.

van Griensven J, Gadisa E, Aseffa A, Hailu A, Beshah AM, Diro E.

PLoS Negl Trop Dis. 2016 Mar 3;10(3):e0004495. doi: 10.1371/journal.pntd.0004495. eCollection 2016 Mar. Review.

Supplemental Content

Loading ...
Support Center